Targeting Phosphatidylserine in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas: A Phase 2 Trial of Bavituximab Plus Pembrolizumab with Biomarker-Correlated Outcomes. - Ntellas, Panagiotis; Park, Haeseong; Culm, Kerry; Lee, Jeeyun; Youssoufian, Hagop; Mockbee, Colleen; Uhlik, Mark; Benjamin, Laura; Chau, Ian (Current Oncology, 2026)